Iron deficiency is the most prevalent nutritional deficiency affecting children and adolescents
worldwide. A consistent body of epidemiological data demonstrates an increased incidence …

Iron deficiency anemia (IDA) continues to be very common worldwide. Intravenous (IV) iron
is an infrequently used therapeutic option in children with IDA despite numerous studies in …

Importance Iron-deficiency anemia (IDA) affects millions of persons worldwide, and is
associated with impaired neurodevelopment in infants and children. Ferrous sulfate is the …

Objective To assess the benefits and risks of intravenous (IV) ferric carboxymaltose (FCM) in
children with iron deficiency anemia (IDA). Study design In a retrospective cohort study of …

Menstruating women, with or without underlying bleeding disorders, are at increased risk for
developing iron deficiency‐related fatigue, even in the absence of anemia. Oral iron therapy …

The efficiency of maghemite nanoparticles for the treatment of anemia was sensibly higher
when nanoparticles were incorporated onto the probiotic bacterium Lactobacillus fermentum …

Limited high‐quality evidence supports the management of iron deficiency anemia (IDA). To
assess our institutional performance in this area, we retrospectively reviewed IDA treatment …

Choosing Wisely is a medical stewardship and quality-improvement initiative led by the
American Board of Internal Medicine Foundation in collaboration with leading medical …

Objective The objective of this single‐center observational study was to determine the
clinical and hematologic responses to intravenous ferric carboxymaltose (FCM) in a cohort …

Background Guidelines for young children with nutritional iron deficiency anemia (IDA)
presenting to the emergency department (ED) are lacking, leading to variability in care. We …